Regeneron Pharmaceuticals (REGN) Debt Ratio (2020 - 2026)

Regeneron Pharmaceuticals' Debt Ratio history runs 7 years deep, the most recent figure standing at 0.05 for Q1 2026.

• In Q1 2026, Debt Ratio fell 8.07% year-over-year to 0.05; the TTM figure through Mar 2026 stood at 0.05 (down 8.07% YoY), while the FY2025 annual figure was 0.05, down 6.83% from the prior year.
• Debt Ratio was 0.05 for Q1 2026 at Regeneron Pharmaceuticals, down from 0.05 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.08 in Q1 2022 to a low of 0.05 in Q1 2026.
• Historically, Debt Ratio has averaged 0.06 across 5 years, with a median of 0.06 in 2024.
• The sharpest annual moves came in 2022 and 2025: Debt Ratio tumbled 32.5% in 2022, then declined 5.51% in 2025.
• A 5-year view of Debt Ratio shows it stood at 0.07 in 2022, then decreased by 11.62% to 0.06 in 2023, then retreated by 12.33% to 0.05 in 2024, then fell by 6.83% to 0.05 in 2025, then slipped by 0.75% to 0.05 in 2026.
• The last three Debt Ratio figures came in at 0.05 (Q1 2026), 0.05 (Q4 2025), and 0.05 (Q3 2025), per Business Quant data.